Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $503.9200 (2.59%) ($487.2400 - $504.9800) on Fri. Oct. 9, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 42 | Latest Price | $503.9200(2.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN declines -3.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(65%) XLV(52%) XBI(49%) QQQ(42%) IWF(41%) | Factors Impacting REGN price | REGN will decline at least -1.395% in a week (0% probabilities). VIXM(-15%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 2% | | | |
|
5 Day Moving Average | $482.77(4.38%) | 10 Day Moving Average | $474.54(6.19%) | 20 Day Moving Average | $501.46(0.49%) | To recent high | -14.9% | To recent low | 11.5% | Market Cap | $53.43b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |